Insulin Glargine vs GLP-1

Head-to-head comparison of Insulin Glargine (Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)) and GLP-1 (Glucagon-like peptide-1 (7-36 amide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin GlargineGLP-1
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameInsulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)Glucagon-like peptide-1 (7-36 amide)
Molecular Weight6063.6 Da3297 Da
Half-LifeAbout 12-24 hours1-2 minutes
Amino Acids5130
Typical Dose0.1-0.2 U/kg once dailyResearch-only: 0.1-1.0 pmol/kg/min
RouteSubcutaneousIntravenous/Subcutaneous
Purity≥98%≥98%
Studies Count130001200
Research StatusApprovedPre-clinical

Insulin Glargine Benefits

  • Once-daily basal coverage
  • Smooth action profile
  • Lower nocturnal hypoglycemia risk
  • Improves fasting glucose control

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Insulin Glargine Dosing

Inject SC once daily at the same time each day|Titrate every 3-4 days to fasting glucose targets|Can be combined with prandial insulin

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Insulin Glargine Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Research Overview

Insulin Glargine

Clinical and translational studies support its use as a basal comparator because of prolonged absorption and stable glycemic control. It is heavily used in basal-bolus regimen research and insulin-delivery optimization studies.

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Glargine stacks with:

Insulin LisproInsulin Aspart

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise
basal insulinlong-actingfasting glucoseincretinbeta-cell survivalDPP-4 substrate